| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
R.GASQNIIPASTGAAK.A 3.24 0.22 693.3760 50.16 - 58.23 2 6.4E5 52.76 200 214 N
K.LTGMAFR.V 0.87 3.96 398.2117 61.46 - 66.66 2 4.7E5 62.73 227 233 N
R.VPTPNVSVVDLTVR.L 2.23 0.14 748.4325 102.57 - 106.21 2 3.5E5 104.28 234 247 N
K.LTGMAFR.V 0.42 7.08 398.2188 59.75 - 63.22 2 3.5E5 61.32 227 233 N
K.VVPELNGK.L Y 0.68 8.19 428.2576 43.12 - 46.95 2 2.7E5 44.76 219 226 Y
K.LVSWYDNEFGYSHR.V Y 2.27 2.50 591.6082 95.35 - 99.61 3 2.1E5 97.17 309 322 Y
R.VVISAPSADAPMFVMGVNHEK.Y Y 1.98 6.68 733.7066 108.35 - 112.60 3 1.8E5 110.39 118 138 Y
K.AAAEGPMK.G Y 0.61 2.49 387.6951 28.94 - 33.16 2 1.3E5 30.27 263 270 N
K.IGINGFGR.I Y 0.14 5.88 417.2361 68.77 - 72.67 2 9.4E4 70.22 4 11 N
K.AAAEGPMK.G Y 0.27 6.65 387.7038 27.76 - 34.07 2 7.3E4 30.07 263 270 N
R.VPTPNVSVVDLTVR.L 1.62 0.47 499.2904 102.53 - 106.24 3 7.2E4 104.27 234 247 N
R.GASQNIIPASTGAAK.A 2.13 0.28 462.5867 50.09 - 58.26 3 7.1E4 52.76 200 214 N
K.GILGYTEDQVVSTDFNGDTR.S Y 0.80 0.35 729.6792 103.92 - 110.55 3 6.5E4 107.68 271 290 N
K.LTGMAFR.V 1.99 4.48 795.4226 59.79 - 66.69 1 5.6E4 62.14 227 233 N
K.VVSNASCTTNCLAPVAK.V Y 1.65 4.04 839.4229 65.32 - 71.26 2 5.2E4 67.66 145 161 N
R.SSIFDAGAGIALNDHFVK.L 0.54 1.24 621.3165 117.15 - 122.59 3 4.9E4 118.76 291 308 N
F.RVPTPNVSVVDLTVR.L 1.28 0.67 551.3245 93.71 - 98.03 3 4.7E4 95.70 233 247 N
R.VCDLVLHMFSK.E Y 1.18 1.91 431.2250 118.50 - 122.42 3 4.5E4 120.34 323 333 N
Y.DNEFGYSHR.V 1.96 1.91 562.7451 37.01 - 46.66 2 4.4E4 39.28 314 322 N
K.AAAEGPMK.G Y 1.05 2.51 774.3907 27.89 - 32.74 1 3.8E4 29.60 263 270 N
K.YDSSMK.V Y 1.01 6.63 365.6568 28.36 - 31.26 2 3.7E4 29.34 139 144 N
K.VVPELNGK.L Y 1.79 2.29 855.4967 43.12 - 51.34 1 3.3E4 45.39 219 226 N
K.GILGYTEDQVVSTDFNGDTR.S Y 1.61 0.20 1094.0177 105.98 - 109.74 2 3E4 107.71 271 290 N
K.L(+43.01)TGMAFR.V 1.59 4.90 419.7173 102.24 - 106.49 2 3E4 104.36 227 233 N Carbamylation
K.RVVISAPSADAPMFVMGVNHEK.Y Y 1.09 1.22 589.5584 100.34 - 105.07 4 2.9E4 102.46 117 138 N
R.VCDLVLHMFSK.E Y 1.01 1.73 646.3376 118.50 - 122.36 2 2.7E4 120.37 323 333 N
K.LVSWYDNEFGYSHR.V Y 1.27 3.28 886.9094 95.08 - 99.28 2 2.6E4 97.17 309 322 N
K.YDDIK.K 0.53 5.15 327.1604 29.92 - 34.18 2 2.6E4 31.07 254 258 N
R.LEKPAKYDDIKK.V 1.05 15.31 483.2825 31.23 - 34.17 3 2.4E4 32.67 248 259 N
K.YDSTHGVWK.L Y 1.79 1.67 364.8434 41.87 - 45.83 3 2.4E4 43.54 47 55 N
K.YDSTHGVWK.L Y 0.92 0.44 546.7675 41.56 - 49.67 2 2.3E4 44.45 47 55 N
K.RVVISAPSADAPMFVMGVNHEK.Y Y 1.05 1.85 785.7405 99.64 - 105.40 3 2.3E4 102.48 117 138 N
R.V(+43.01)CDLVLHMFSK.E Y 1.37 0.52 445.5605 111.83 - 116.25 3 2.2E4 114.13 323 333 N Carbamylation
R.VC(+57.02)DLVLHMFSK.E Y 1.00 4.29 450.2326 108.57 - 112.83 3 2.2E4 110.71 323 333 N Carbamidomethylation
Y.DNEFGYSHR.V 0.87 6.75 375.4951 37.90 - 46.17 3 2.2E4 40.16 314 322 N
K.VVSNASCTTNCLAPVAK.V Y 0.49 2.29 559.9481 66.76 - 70.90 3 2.1E4 68.00 145 161 N
K.IGINGFGR.I Y 0.02 5.08 417.2335 68.59 - 72.01 2 2.1E4 69.90 4 11 N
R.SSIFDAGAGIALNDHFVK.L 0.15 2.41 621.3225 117.72 - 122.59 3 2.1E4 119.83 291 308 N
K.V(+43.01)VSNASCTTNCLAPVAK.V Y 1.21 2.41 860.9251 62.80 - 68.66 2 2.1E4 64.97 145 161 N Carbamylation
R.LEKPAKYDDIKK.V 0.71 10.31 362.7139 32.81 - 34.30 4 1.9E4 33.52 248 259 N
K.YDDIK.K 0.86 0.26 653.3187 29.40 - 33.91 1 1.9E4 30.71 254 258 N
Y.VVESTGVFTTIEK.A 0.91 4.23 705.3792 82.42 - 85.83 2 1.8E4 83.87 94 106 N
K.YDSSMK.V Y 0.43 4.11 365.6661 27.40 - 29.78 2 1.5E4 28.75 139 144 N
K.VVSNASCTTNCLAPVAK(+43.01).V Y 1.19 2.05 860.9258 60.89 - 64.11 2 1.5E4 62.80 145 161 N Carbamylation
K.YDSTHGVWK.L Y 0.50 2.59 546.7754 43.60 - 51.78 2 1.2E4 45.82 47 55 N
R.VVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.33 3.28 728.3605 107.41 - 110.39 4 1.2E4 108.92 118 144 N
R.VC(+57.02)DLVLHMFSK.E Y 0.88 4.23 674.8471 108.61 - 111.40 2 1.2E4 110.19 323 333 N Carbamidomethylation
K.VVSNASC(+57.02)TTNCLAPVAK.V Y 1.24 0.34 867.9330 59.96 - 66.32 2 1.1E4 62.28 145 161 N Carbamidomethylation
E.YMVYMFK.Y 0.52 3.63 491.2386 95.22 - 99.03 2 1.1E4 97.44 40 46 N
N.VSVVDLTVR.L 1.41 2.98 494.2986 81.26 - 85.91 2 1.1E4 83.51 239 247 N
R.VPTPNVSVVD(+21.98)LTVR.L 1.52 1.93 506.6162 102.53 - 106.08 3 1.1E4 104.19 234 247 N Sodium adduct
K.DPANIK.W 0.16 5.43 329.1814 28.44 - 33.09 2 1.1E4 30.00 80 85 N
R.SSIFDAGAGIALNDHFVK.L 0.67 0.00 931.4725 117.77 - 121.45 2 1E4 119.01 291 308 N
R.L(+43.01)EKPAK.Y 0.15 1.90 364.7157 30.98 - 32.77 2 9.3E3 31.75 248 253 N Carbamylation
R.VCDLVLHMF.S Y 1.53 2.22 538.7696 131.85 - 133.10 2 9.2E3 132.39 323 331 N
K.RVVISAPSADAPMFVMGVNHEK.Y Y 0.42 0.38 785.7370 101.27 - 104.86 3 8.7E3 103.04 117 138 N
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 0.73 0.79 867.9302 57.71 - 63.55 2 8.4E3 59.71 145 161 N Carbamidomethylation
M.VKIGINGFGR.I Y 1.24 9.26 354.2143 71.45 - 76.78 3 7.5E3 73.68 2 11 N
K.VVNDNFVIVEGLMSTVH.A Y 1.20 1.74 936.9830 133.25 - 134.23 2 7.5E3 133.69 162 178 N
K.VVSNASC(+57.02)TTNC(+57.02)LAPVAK.V Y 0.03 2.46 597.9606 52.99 - 58.56 3 7.2E3 54.96 145 161 N Carbamidomethylation
K.AAAEGPMK.G Y 0.01 3.98 387.7063 27.42 - 30.48 2 6.6E3 29.25 263 270 N
R.LEKPAKYDDIKK.V 1.13 17.02 724.4210 31.34 - 34.27 2 6.5E3 32.77 248 259 N
M.STVHAITATQK.T Y 0.31 0.50 578.8215 31.96 - 38.64 2 6E3 33.43 175 185 N
K.RVVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.15 0.59 767.3823 100.61 - 102.69 4 5.8E3 101.56 117 144 N
K.RVVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.21 4.36 614.1051 100.33 - 102.18 5 5.8E3 101.00 117 144 N
K.VVSNASC(+57.02)TTNC(+57.02)LAPVAK.V Y 0.39 2.10 896.4530 49.24 - 58.96 2 5.7E3 53.81 145 161 N Carbamidomethylation
K.WGDAGADYVVESTGVFTTIEK.A Y 0.40 2.89 749.0283 128.85 - 133.85 3 5.4E3 130.88 86 106 N
D.APMFVMGVNHEK.Y 0.90 1.42 453.8926 69.73 - 73.14 3 5E3 71.75 127 138 N
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 1.13 21.59 867.9388 70.03 - 73.04 2 4.6E3 71.69 145 161 N Carbamidomethylation
R.V(+43.01)CDLVLHMFSK.E Y 0.09 0.93 667.8394 110.86 - 115.68 2 4.1E3 113.54 323 333 N Carbamylation
R.VC(+57.02)DLVLHMF.S Y 0.74 0.06 567.2832 128.79 - 130.26 2 3.9E3 129.52 323 331 N Carbamidomethylation
R.V(+43.01)CDLVLHMF.S Y 0.65 5.39 560.2704 130.46 - 131.75 2 3.6E3 131.13 323 331 N Carbamylation
R.VCDLVLHMFSKE Y 1.11 11.63 474.2418 120.60 - 122.90 3 3.6E3 122.00 323 334 N
K.I(+43.01)GINGFGR.I Y 0.24 6.02 438.7458 93.04 - 95.72 2 3.4E3 94.46 4 11 N Carbamylation
K.LVIGNMHITVFHEKDPANIK.W Y 0.24 0.99 569.8118 97.20 - 100.07 4 3.2E3 98.39 66 85 N
R.LEKPAKYDDIK.K 0.07 1.05 660.3528 37.36 - 39.61 2 3E3 38.28 248 258 N
R.VC(+57.02)DLVLHMFSKE Y 0.19 4.93 493.2496 111.33 - 113.40 3 2.4E3 112.31 323 334 N Carbamidomethylation
R.V(+43.01)C(+45.99)DLVLHMFSK.E Y 1.14 0.29 460.8891 114.56 - 117.20 3 1.9E3 116.27 323 333 N Carbamylation; Beta-methylthiolation
K.LVIGNMHITVFHEKDPANIK.W Y 0.27 0.07 456.0503 97.10 - 99.04 5 1.5E3 98.13 66 85 N
total 79 peptides